Joint Pain News and Research

RSS

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Scientists develop artificial intelligence platform to diagnose many diseases

A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil

13 Jun 2018

Limiting global warming could reduce millions of dengue cases every year

Limiting global warming to 1.5°C could avoid around 3.3 million cases of dengue fever per year in Latin America and the Caribbean alone - according to new research from the University of East Anglia.

28 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

Chikungunya virus is a growing threat to the United States and other regions of the world as the mosquito that carries the virus expands its reach. Telltale symptoms of chikungunya infection are fever and joint pain that last about a week.

17 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.

15 Feb 2018

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers.

13 Feb 2018

Many Indians put away treating orthopedic problems

While India has witnessed an increase in life expectancy thanks to advances in medical science and technology, what is also increasing is the number of people leading sedentary lifestyles and eating food that is unhealthy.

22 Jan 2018

Flu can be spread without coughs and sneezes

A study published yesterday in the Proceedings of the National Academy of Sciences reports that it is easier to spread the influenza virus than was previously thought.

19 Jan 2018

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

15 Jan 2018

Online interactive app motivates diabetes patients to increase physical activity

As the holidays draw to a close, 29 million Americans with type 2 diabetes had to navigate the minefield of treats, drinks, and dinners. Many patients have stepped up to meet the challenge of moderating their diet, but fewer embrace the benefits of physical activity in controlling their blood sugar.

10 Jan 2018

Joint Pain News and Research

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Scientists develop artificial intelligence platform to diagnose many diseases

Limiting global warming could reduce millions of dengue cases every year

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Scientists identify new drug target to combat chikungunya virus

Study finds molecular handle that chikungunya virus uses to enter into cells and cause arthritis

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

FDA approves new treatment for non-metastatic, castration-resistant prostate cancer

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Many Indians put away treating orthopedic problems

Flu can be spread without coughs and sneezes

FDA grants approval for first drug to treat inherited breast cancer

Online interactive app motivates diabetes patients to increase physical activity

UGR study paves way for development of better analgesics to treat joint pain

Valley fever cases see sharp increase in November, say UVA experts

Dengue vaccine issues in the Philippines

UT Southwestern researchers identify potential approach to suppress lethal parasitic infections

Immune system plays key role in amount of osteoarthritic pain and progression

Controlling organ functions with your cell phone may be possible in future

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News